Animal models of lupus nephritis: the past, present and a future outlook

References

• Brunner HI, Gladman DD, Ibañez D, et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58(2):1–8.
   Google Scholar
• Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med. 2012;18(6):871–882.
   PubMed Web of Science ®Google Scholar
• Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110–2121.
   PubMed Web of Science ®Google Scholar
• Rullo OJ, Tsao BP. Recent insights into the genetic basis of systemic lupus erythematosus. Ann Rheum Dis. 2013;72 Suppl 2(0 2):ii56–61.
   PubMedGoogle Scholar
• Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–835.
   PubMed Web of Science ®Google Scholar
• Madaio MP. The role of autoantibodies in the pathogenesis of lupus nephritis. Semin Nephrol. 1999;19(1):48–56.
   PubMed Web of Science ®Google Scholar
• Fogo AB, Lusco MA, Najafian B, et al. AJKD atlas of renal pathology: focal and diffuse lupus nephritis (ISN/RPS class III and IV). Am J Kidney Dis. 2017;70(2):e9–e11.
   PubMed Web of Science ®Google Scholar
• Londoño Jimenez A, Mowrey WB, Putterman C, et al. Brief report: tubulointerstitial damage in lupus nephritis: a comparison of the factors associated with tubulointerstitial inflammation and renal scarring. Arthritis Rheumatol. 2018;70(11):1801–1806.
   PubMed Web of Science ®Google Scholar
• Rijnink EC, Teng YKO, Wilhelmus S, et al. Clinical and histopathologic characteristics associated with renal outcomes in lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):734–743.
   PubMed Web of Science ®Google Scholar
• Hong S, Healy H, Kassianos AJ. The emerging role of renal tubular epithelial cells in the immunological pathophysiology of lupus nephritis. Front Immunol. 2020;11:578952.
   PubMed Web of Science ®Google Scholar
• Wilson PC, Kashgarian M, Moeckel G. Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis. Clin Kidney J. 2018;11(2):207–218.
   PubMed Web of Science ®Google Scholar
• Chung SA, Brown EE, Williams AH, et al. Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. J Am Soc Nephrol. 2014;25(12):2859–2870.
   PubMed Web of Science ®Google Scholar
• Caza T, Wijewardena C, Al-Rabadi L, et al. Cell type-specific mechanistic target of rapamycin-dependent distortion of autophagy pathways in lupus nephritis. Transl Res. 2022;245:55–81.
   PubMed Web of Science ®Google Scholar
• Wang A, Zhao J, Qin Y, et al. Alterations of the gut microbiota in the lupus nephritis: a systematic review. Ren Fail. 2023;45(2):2285877.
   PubMed Web of Science ®Google Scholar
• Wang W, Lin Z, Feng J, et al. Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis. Lupus. 2022;31(8):985–997.
   PubMed Web of Science ®Google Scholar
• Vinuesa CG, Shen N, Ware T. Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants. Nat Rev Nephrol. 2023;19(9):558–572.
   PubMed Web of Science ®Google Scholar
• Morel L. Genetics of SLE: evidence from mouse models. Nat Rev Rheumatol. 2010;6(6):348–357.
   PubMed Web of Science ®Google Scholar
• Barnes BJ. Genetic versus non-genetic drivers of SLE: implications of IRF5 dysregulation in both roads leading to SLE. Curr Rheumatol Rep. 2019;21(1):2.
   PubMed Web of Science ®Google Scholar
• Sang A, Yin Y, Zheng YY, et al. Animal models of molecular pathology systemic lupus erythematosus. Prog Mol Biol Transl Sci. 2012;105:321–370.
   PubMed Web of Science ®Google Scholar
• Toumi E, Mezouar S, Plauzolles A, et al. Gut microbiota in SLE: from animal models to clinical evidence and pharmacological perspectives. Lupus Sci Med. 2023;10(1):e000776.
   PubMed Web of Science ®Google Scholar
• Ma L, Roach T, Morel L. Immunometabolic alterations in lupus: where do they come from and where do we go from there? Curr Opin Immunol. 2022;78:102245.
   PubMed Web of Science ®Google Scholar
• Wlazlo E, Mehrad B, Morel L, et al. Iron metabolism: an under investigated driver of renal pathology in lupus nephritis. Front Med (Lausanne). 2021;8:643686.
   PubMed Web of Science ®Google Scholar
• Scindia Y, Wlazlo E, Ghias E, et al. Modulation of iron homeostasis with hepcidin ameliorates spontaneous murine lupus nephritis. Kidney Int. 2020;98(1):100–115.
   PubMed Web of Science ®Google Scholar
• Rauch J, Murphy E, Roths JB, et al. A high frequency idiotypic marker of anti-DNA autoantibodies in MRL-Ipr/ipr mice. J Immunol. 1982;129(1):236–241.
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390.
   PubMed Web of Science ®Google Scholar
• Crispín JC, Oukka M, Bayliss G, et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol. 2008;181(12):8761–8766.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Rodríguez N, Apostolidis SA, Fitzgerald L, et al. Pro-inflammatory self-reactive T cells are found within murine TCR-alphabeta(+) CD4(-) CD8(-) PD-1(+) cells. Eur J Immunol. 2016;46(6):1383–1391.
   PubMed Web of Science ®Google Scholar
• Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9(1):243–269.
   PubMedGoogle Scholar
• Andrews BS, Eisenberg RA, Theofilopoulos AN, et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978;148(5):1198–1215.
   PubMed Web of Science ®Google Scholar
• Christensen SR, Shupe J, Nickerson K, et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006;25(3):417–428.
   PubMed Web of Science ®Google Scholar
• Teichmann LL, Schenten D, Medzhitov R, et al. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity. 2013;38(3):528–540.
   PubMed Web of Science ®Google Scholar
• Ols ML, Cullen JL, Turqueti-Neves A, et al. Dendritic cells regulate extrafollicular autoreactive B cells via T cells expressing fas and fas ligand. Immunity. 2016;45(5):1052–1065.
   PubMed Web of Science ®Google Scholar
• Tilstra JS, Avery L, Menk AV, et al. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J Clin Invest. 2018;128(11):4884–4897.
   PubMed Web of Science ®Google Scholar
• Bao L, Haas M, Quigg RJ. Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol. 2011;22(2):285–295.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Garnier G, Circolo A, et al. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B. J Immunol. 2000;164(2):786–794.
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Watanabe N, Akikusa B, et al. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice. Arthritis Rheum. 2003;48(2):486–494.
   PubMedGoogle Scholar
• Vidal S, Kono DH, Theofilopoulos AN. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J Clin Invest. 1998;101(3):696–702.
   PubMed Web of Science ®Google Scholar
• Kyttaris VC, Zhang Z, Kuchroo VK, et al. Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J Immunol. 2010;184(9):4605–4609.
   PubMed Web of Science ®Google Scholar
• Ramani K, Biswas PS. Interleukin 17 signaling drives type I interferon induced proliferative crescentic glomerulonephritis in lupus-prone mice. Clin Immunol. 2016;162:31–36.
   PubMed Web of Science ®Google Scholar
• Li P, Jiang M, Li K, et al. Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nat Immunol. 2021;22(9):1107–1117.
   PubMed Web of Science ®Google Scholar
• Marinov AD, Wang H, Bastacky SI, et al. The type II anti-CD20 antibody obinutuzumab (GA101) is more effective than rituximab at depleting B cells and treating disease in a murine lupus model. Arthritis Rheumatol. 2021;73(5):826–836.
   PubMed Web of Science ®Google Scholar
• Blanco LP, Pedersen HL, Wang X, et al. Improved mitochondrial metabolism and reduced inflammation following attenuation of murine lupus with coenzyme Q10 analog idebenone. Arthritis Rheumatol. 2020;72(3):454–464.
   PubMed Web of Science ®Google Scholar
• Maibaum MA, Haywood ME, Walport MJ, et al. Lupus susceptibility loci map within regions of BXSB derived from the SB/Le parental strain. Immunogenetics. 2000;51(4–5):370–372.
   PubMed Web of Science ®Google Scholar
• Murphy ED, Roths JB. A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 1979;22(11):1188–1194.
   PubMedGoogle Scholar
• Hudgins CC, Steinberg RT, Klinman DM, et al. Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J Immunol. 1985;134(6):3849–3854.
   PubMed Web of Science ®Google Scholar
• Pisitkun P, Deane JA, Difilippantonio MJ, et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006;312(5780):1669–1672.
   PubMed Web of Science ®Google Scholar
• Subramanian S, Tus K, Li QZ, et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A. 2006;103(26):9970–9975.
   PubMed Web of Science ®Google Scholar
• Han S, Zhuang H, Shumyak S, et al. Mechanisms of autoantibody production in systemic lupus erythematosus. Front Immunol. 2015;6:228.
   PubMed Web of Science ®Google Scholar
• McGaha TL, Sorrentino B, Ravetch JV. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science. 2005;307(5709):590–593.
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Dixon FJ. Etiopathogenesis of murine SLE. Immunol Rev. 1981;55(1):179–216.
   PubMedGoogle Scholar
• Yoshida H, Fujiwara H, Fujiwara T, et al. Quantitative analysis of myocardial infarction in (NZW x BXSB)F1 hybrid mice with systemic lupus erythematosus and small coronary artery disease. Am J Pathol. 1987;129(3):477–485.
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Kawamura M, Ichikawa K, et al. Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome. J Immunol. 1992;149(3):1063–1068.
   PubMed Web of Science ®Google Scholar
• Akkerman A, Huang W, Wang X, et al. CTLA4Ig prevents initiation but not evolution of anti-phospholipid syndrome in NZW/BXSB mice. Autoimmunity. 2004;37(6–7):445–451.
   PubMed Web of Science ®Google Scholar
• Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med. 2002; 346(10):752–763.
   PubMed Web of Science ®Google Scholar
• Helyer BJ, Howie JB. Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature. 1963;197(4863):197–197.
   PubMedGoogle Scholar
• Rudofsky UH, Evans BD, Balaban SL, et al. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Lab Invest. 1993;68(4):419–426.
   PubMed Web of Science ®Google Scholar
• Papoian R, Pillarisetty R, Talal N. Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice. Immunology. 1977;32(1):75–79.
   PubMed Web of Science ®Google Scholar
• Ramanujam M, Wang X, Huang W, et al. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J Clin Invest. 2006;116(3):724–734.
   PubMed Web of Science ®Google Scholar
• Liu Z, Bethunaickan R, Huang W, et al. IFN-alpha confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice. J Immunol. 2011;187(3):1506–1513.
   PubMed Web of Science ®Google Scholar
• Berthier CC, Kretzler M, Davidson A. From the large scale expression analysis of lupus nephritis to targeted molecular medicine. J Data Mining Genomics Proteomics. 2012; 3(3):1000123.
   PubMedGoogle Scholar
• Cornaby C, Elshikha AS, Teng X, et al. Efficacy of the combination of metformin and CTLA4Ig in the (NZB x NZW)F1 mouse model of lupus nephritis. Immunohorizons. 2020;4(6):319–331.
   PubMedGoogle Scholar
• Morel L, Rudofsky UH, Longmate JA, et al. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity. 1994;1(3):219–229.
   PubMed Web of Science ®Google Scholar
• Morel L. Mapping lupus susceptibility genes in the NZM2410 mouse model. Adv Immunol. 2012;115:113–139.
   PubMed Web of Science ®Google Scholar
• Morel L, Croker BP, Blenman KR, et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc Natl Acad Sci U S A. 2000;97(12):6670–6675.
   PubMed Web of Science ®Google Scholar
• Teng X, Brown J, Choi SC, et al. Metabolic determinants of lupus pathogenesis. Immunol Rev. 2020;295(1):167–186.
   PubMed Web of Science ®Google Scholar
• Yin Y, Choi SC, Xu Z, et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci Transl Med. 2015;7(274):274ra18.
   PubMed Web of Science ®Google Scholar
• Yin Y, Choi SC, Xu Z, et al. Glucose oxidation is critical for CD4+ T cell activation in a mouse model of systemic lupus erythematosus. J Immunol. 2016;196(1):80–90.
   PubMed Web of Science ®Google Scholar
• Sisirak V, Ganguly D, Lewis KL, et al. Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J Exp Med. 2014;211(10):1969–1976.
   PubMed Web of Science ®Google Scholar
• Sobel ES, Mohan C, Morel L, et al. Genetic dissection of SLE pathogenesis: adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells. J Immunol. 1999;162(4):2415–2421.
   PubMed Web of Science ®Google Scholar
• Rudofsky UH, Lawrence DA. New Zealand mixed mice: a genetic systemic lupus erythematosus model for assessing environmental effects. Environ Health Perspect. 1999; 107 Suppl 5(Suppl 5):713–721.
   PubMedGoogle Scholar
• Waters ST, Fu SM, Gaskin F, et al. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin Immunol. 2001;100(3):372–383.
   PubMed Web of Science ®Google Scholar
• Ge Y, Brown MG, Wang H, et al. Genetic approach to study lupus glomerulonephritis. Methods Mol Biol. 2012;900:271–290.
   PubMedGoogle Scholar
• Bagavant H, Deshmukh US, Wang H, et al. Role for nephritogenic T cells in lupus glomerulonephritis: progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes. J Immunol. 2006;177(11):8258–8265.
   PubMed Web of Science ®Google Scholar
• Bagavant H, Kalantarinia K, Scindia Y, et al. Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice. Am J Kidney Dis. 2011;57(3):498–507.
   PubMed Web of Science ®Google Scholar
• Deshmukh US, Bagavant H, Fu SM. Role of anti-DNA antibodies in the pathogenesis of lupus nephritis. Autoimmun Rev. 2006;5(6):414–418.
   PubMed Web of Science ®Google Scholar
• Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994;180(6):2341–2346.
   PubMed Web of Science ®Google Scholar
• Satoh M, Kumar A, Kanwar YS, et al. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci U S A. 1995;92(24):10934–10938.
   PubMed Web of Science ®Google Scholar
• Reeves WH, Lee PY, Weinstein JS, et al. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol. 2009;30(9):455–464.
   PubMed Web of Science ®Google Scholar
• Chowdhary VR, Grande JP, Luthra HS, et al. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of pristane-induced lupus. Rheumatology (Oxford). 2007;46(9):1405–1410.
   PubMed Web of Science ®Google Scholar
• Nguyen VA, Gotwald T, Prior C, et al. Acute pulmonary edema, capillaritis and alveolar hemorrhage: pulmonary manifestations coexistent in antiphospholipid syndrome and systemic lupus erythematosus? Lupus. 2005;14(7):557–560.
   PubMed Web of Science ®Google Scholar
• Wooley PH, Seibold JR, Whalen JD, et al. Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum. 1989;32(8):1022–1030.
   PubMedGoogle Scholar
• Smith DL, Dong X, Du S, et al. A female preponderance for chemically induced lupus in SJL/J mice. Clin Immunol. 2007;122(1):101–107.
   PubMed Web of Science ®Google Scholar
• Zhuang H, Szeto C, Han S, et al. Animal models of interferon signature positive lupus. Front Immunol. 2015;6:291.
   PubMed Web of Science ®Google Scholar
• Bossaller L, Christ A, Pelka K, et al. TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in Pristane-Induced murine lupus. J Immunol. 2016;197(4):1044–1053.
   PubMed Web of Science ®Google Scholar
• Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967; 126(6):989–1004.
   PubMed Web of Science ®Google Scholar
• Dammacco F, Battaglia S, Gesualdo L, et al. Goodpasture’s disease: a report of ten cases and a review of the literature. Autoimmun Rev. 2013;12(11):1101–1108.
   PubMed Web of Science ®Google Scholar
• Groggel GC, Salant DJ, Darby C, et al. Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis. Kidney Int. 1985;27(4):643–651.
   PubMed Web of Science ®Google Scholar
• Park SY, Ueda S, Ohno H, et al. Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. J Clin Invest. 1998;102(6):1229–1238.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Nimmerjahn F, Madaio MP, et al. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med. 2006;203(3):789–797.
   PubMed Web of Science ®Google Scholar
• Sheerin NS, Springall T, Carroll MC, et al. Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice. Clin Exp Immunol. 1997;110(3):403–409.
   PubMed Web of Science ®Google Scholar
• Hébert MJ, Takano T, Papayianni A, et al. Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol Dial Transplant. 1998;13(11):2799–2803.
   PubMed Web of Science ®Google Scholar
• Schrijver G, Bogman MJ, Assmann KJ, et al. Anti-GBM nephritis in the mouse: role of granulocytes in the heterologous phase. Kidney Int. 1990;38(1):86–95.
   PubMed Web of Science ®Google Scholar
• Hochheiser K, Engel DR, Hammerich L, et al. Kidney dendritic cells become pathogenic during crescentic glomerulonephritis with proteinuria. J Am Soc Nephrol. 2011;22(2):306–316.
   PubMed Web of Science ®Google Scholar
• Tipping PG, Holdsworth SR. T cells in crescentic glomerulonephritis. J Am Soc Nephrol. 2006;17(5):1253–1263.
   PubMed Web of Science ®Google Scholar
• Paust HJ, Turner JE, Steinmetz OM, et al. The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J Am Soc Nephrol. 2009;20(5):969–979.
   PubMed Web of Science ®Google Scholar
• Alli AA, Desai D, Elshika A, et al. Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis. Clin Immunol. 2023;248:109213.
   PubMed Web of Science ®Google Scholar
• Soloviova K, Puliaiev M, Foster A, et al. The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function. Methods Mol Biol. 2012;900:253–270.
   PubMedGoogle Scholar
• Morris SC, Cohen PL, Eisenberg RA. Experimental induction of systemic lupus erythematosus by recognition of foreign Ia. Clin Immunol Immunopathol. 1990;57(2):263–273.
   PubMedGoogle Scholar
• Morris SC, Cheek RL, Cohen PL, et al. Allotype-specific immunoregulation of autoantibody production by host B cells in chronic graft-versus host disease. J Immunol. 1990;144(3):916–922.
   PubMed Web of Science ®Google Scholar
• Morris SC, Cheek RL, Cohen PL, et al. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med. 1990;171(2):503–517.
   PubMed Web of Science ®Google Scholar
• Chen F, Maldonado MA, Madaio M, et al. The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease. J Immunol. 1998;161(11):5880–5885.
   PubMed Web of Science ®Google Scholar
• Choudhury A, Cohen PL, Eisenberg RA. B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus. Clin Immunol. 2010;136(1):105–115.
   PubMed Web of Science ®Google Scholar
• Han X, Gu S, Hong SM, et al. Amelioration of autoimmunity in a lupus mouse model by modulation of T-Bet-Promoted energy metabolism in pathogenic age/autoimmune-associated B cells. Arthritis Rheumatol. 2023;75(7):1203–1215.
   PubMed Web of Science ®Google Scholar
• Shay T, Jojic V, Zuk O, et al. Conservation and divergence in the transcriptional programs of the human and mouse immune systems. Proc Natl Acad Sci U S A. 2013;110(8):2946–2951.
   PubMed Web of Science ®Google Scholar
• Koboziev I, Jones-Hall Y, Valentine JF, et al. Use of humanized mice to study the pathogenesis of autoimmune and inflammatory diseases. Inflamm Bowel Dis. 2015;21(7):1652–1673.
   PubMed Web of Science ®Google Scholar
• Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129(7):1401–1414.
   PubMed Web of Science ®Google Scholar
• Noviello TMR, Di Liddo A, Ventola GM, et al. Detection of long non-coding RNA homology, a comparative study on alignment and alignment-free metrics. BMC Bioinf. 2018;19(1):407.
   PubMedGoogle Scholar
• Chen J, Liao S, Zhou H, et al. Humanized mouse models of systemic lupus erythematosus: opportunities and challenges. Front Immunol. 2021;12:816956.
   PubMed Web of Science ®Google Scholar
• Khodoun M, Chimote AA, Ilyas FZ, et al. Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus. Sci Adv. 2020;6(47):eabd1471.
   PubMed Web of Science ®Google Scholar
• Gunawan M, Her Z, Liu M, et al. A novel human systemic lupus erythematosus model in humanised mice. Sci Rep. 2017;7(1):16642.
   PubMedGoogle Scholar
• Horton R, Wilming L, Rand V, et al. Gene map of the extended human MHC. Nat Rev Genet. 2004;5(12):889–899.
   PubMed Web of Science ®Google Scholar
• Taylor KE, Chung SA, Graham RR, et al. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet. 2011;7(2):e1001311.
   PubMed Web of Science ®Google Scholar
• Freedman BI, Langefeld CD, Andringa KK, et al. End-stage renal disease in african americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 2014;66(2):390–396.
   PubMed Web of Science ®Google Scholar